Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
37.36
-0.76 (-1.99%)
At close: Aug 15, 2025, 3:59 PM
36.48
-2.36%
After-hours: Aug 15, 2025, 07:58 PM EDT
Apogee Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | n/a | -9.82 | -9.3 | -17.02 | -16.12 | -25.43 | -11.15 | -12.95 | -14.24 | -21.47 | -19.2 | -13.68 | -148.1 | -62.47 |
PEG Ratio | n/a | 0.44 | -0.22 | -0.39 | 2.58 | -16.02 | -0.21 | -1.2 | -0.3 | 2.00 | 0.68 | -0.01 | 2.56 | n/a |
PS Ratio | n/a | n/a | 19.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.10 | 3.23 | 2.45 | 4.54 | 2.82 | 4.07 | 3.73 | 2.64 | -15.11 | -20.57 | -27.04 | n/a | n/a | n/a |
P/FCF Ratio | -40.41 | -41.18 | -36.92 | -77.09 | -74.29 | -102.07 | -47.3 | -54.29 | -73.84 | -101.91 | -117.08 | -148.63 | n/a | n/a |
P/OCF Ratio | -40.91 | -44.85 | -36.92 | -78.45 | -74.41 | -103.2 | -47.57 | -54.29 | -73.84 | -101.91 | -117.08 | -148.63 | n/a | n/a |
OCF/S Ratio | n/a | n/a | -520.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 16.36 | 15.82 | 18.55 | 16.39 | 27.70 | 38.08 | 19.38 | 24.82 | 7.42 | 12.69 | 15.24 | n/a | n/a | n/a |
Current Ratio | 16.36 | 15.82 | 18.55 | 16.39 | 27.70 | 38.08 | 19.38 | 24.82 | 7.42 | 12.69 | 15.24 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.15 | n/a | n/a |
Return on Equity | n/a | -0.08 | -0.07 | -0.07 | -0.04 | -0.04 | -0.08 | -0.05 | 0.27 | 0.24 | 0.35 | n/a | n/a | n/a |
Return on Assets | n/a | -0.08 | -0.09 | -0.06 | -0.04 | -0.04 | -0.08 | -0.05 | -0.14 | -0.09 | -0.09 | n/a | n/a | n/a |
Return on Invested Capital | n/a | -0.09 | -0.1 | -0.08 | -0.06 | -0.05 | -0.1 | -0.06 | -0.16 | -0.1 | -0.1 | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -517.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -516.92 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -583.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -583.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |